No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 |
Allo-hmscs |
- |
- |
- |
- |
[2] 211, 299 |
2 |
Ambrisentan |
Ambrisentan |
D07077 |
[1] EDNRA |
[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
[6] 51, 84, 85, 86, 88, 211 |
3 |
Autologous (self) mononuclear cells derived from umbilical cord blood |
- |
- |
- |
- |
[1] 211 |
4 |
Autologous cell-based delivery |
- |
- |
- |
- |
[1] 211 |
5 |
Autologous human placental cord blood mononuclear cells |
- |
- |
- |
- |
[1] 211 |
6 |
Autologous umbilical cord blood |
- |
- |
- |
- |
[2] 211, 294 |
7 |
C-kit+ cells |
- |
- |
- |
- |
[1] 211 |
8 |
Erythropoetin |
- |
- |
- |
- |
[1] 211 |
9 |
Longeveron mesenchymal stem cells |
- |
- |
- |
- |
[1] 211 |
10 |
Maternal hyperoxygenation |
- |
- |
- |
- |
[1] 211 |
11 |
Nitrogen |
Nitrogen |
D00083 |
- |
- |
[5] 5, 6, 17, 211, 299 |
12 |
Normal saline |
- |
- |
- |
- |
[14] 6, 17, 22, 36, 46, 49, 60, 94, 96, 211, 226, 276, 296, 299 |
13 |
Oxandrolone |
Oxandrolone |
D00462 |
[1] AR |
[3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
[2] 211, 285 |
14 |
Sildenafil |
Sildenafil |
D02229, D08514 |
[1] PDE5A |
[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
[15] 6, 46, 50, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
15 |
Tracleer |
Bosentan |
D01227, D07538 |
[2] EDNRA, EDNRB |
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
[8] 13, 51, 84, 85, 86, 88, 210, 211 |
16 |
Vitamin c |
Ascorbic acid |
D00018 |
- |
- |
[5] 10, 192, 206, 211, 212 |